Cardiovascular Benefits

3 min · 5. März 2024

Beschreibung

* FDA Indications * Clinical Trial Evidence

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists-Community!

7 Folgen

Cardiologist Collaboration

Role in Diabetes Management Multidisciplinary Team-based Approach

Individualizing Therapy

Drug Initiation and Monitoring Contraindications and Adverse Effects Patient Education

Cardiovascular Benefits

* FDA Indications * Clinical Trial Evidence

Glycemic/Non-Glycemic Effects

Short-Acting versus Long-Acting Agents Fasting and Postprandial Blood Glucose Gastric Emptying and Body Weight

Pathophysiologic Targets

Diabetes Pathophysiology Glucagon-Like Peptide-1 Mechanisms